This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
George Shrady, MS
Advertisement
Articles by George Shrady, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Brain Imaging Study Links Long COVID to Dopamine Neuron Injury, Pointing to Repurposed Treatments
2
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
3
How AON Supports Safe Outpatient Bispecific Therapy in Community Oncology
4
Chronic Low Back Pain Treatments Must Be Weighed Against Risk, Cost, and Limited Benefit
5